Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Portfolio Pulse from Lisa Levin
Several stocks experienced significant movement in Tuesday's mid-day session. Soleno Therapeutics, Femasys, Intercept Pharmaceuticals, Immunovant, Tharimmune, Acasti Pharma, Cano Health, Bullfrog AI Holdings, Avalo Therapeutics, Adaptive Biotechnologies, Infobird, ARS Pharmaceuticals, Roivant Sciences, Verve Therapeutics, Pliant Therapeutics, Fisker, Planet Green Holdings, BYND Cannasoft Enterprises, Acutus Medical, Aclarion, Vera Therapeutics, Blue Star Foods, NightHawk Biosciences, and Precigen saw gains. Meanwhile, TransCode Therapeutics, Murphy Canyon Acquisition, Davis Commodities, Molekule Group, Polished.com, United Natural Foods, MicroAlgo, Genetron Holdings, Greenfire Resources, Novo Integrated Sciences, Ebix, New Pacific Metals, Biophytis, Roadzen, Akili, FaZe Holdings, MSP Recovery, TROOPS, Sacks Parente Golf, and TD SYNNEX experienced losses.
September 26, 2023 | 4:56 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Soleno Therapeutics shares jumped 318.5% after releasing top-line results from a study of DCCR for Prader-Willi Syndrome.
Positive study results typically lead to a rise in stock price.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
TD SYNNEX shares fell 5.2% after reporting a third-quarter revenue decline of 9.1% Y/Y, missing the consensus.
Missing revenue consensus typically leads to a drop in stock price.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100